|
|
???tair.name??? >
???browser.page.title.author???
|
"chiu cf"???jsp.browse.items-by-author.description???
Showing items 46-95 of 115 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2016-07 |
Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL
|
Chang, TY;Chen, HA;Chiu, CF;Chang, YW;Kuo, TC;Tseng, PC;Wang, W;Hung, MC;Su, JL |
| 國家衛生研究院 |
2016-05 |
Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine
|
Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, FS;Moyo, VM;Belanger, B;Bayever, E;Von Hoff, DD;Chen, LT |
| 國家衛生研究院 |
2016-04-18 |
NF-kappaB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance
|
Chiu, CF;Chang, YW;Kuo, KT;Shen, YS;Liu, CY;Yu, YH;Cheng, CC;Lee, KY;Chen, FC;Hsu, MK;Kuo, TC;Ma, JT;Su, JL |
| 國家衛生研究院 |
2016-02 |
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial
|
Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, G;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, RA;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, F;Moyo, V;Belanger, B;Dhindsa, N;Bayever, E;Von Hoff, DD;Chen, LT;the NAPOLI-1 Study Group. |
| 國家衛生研究院 |
2016-02 |
Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Siveke, JT;Chen, LT;Von Hoff, DD;Li, CP;Wang-Gillam, A;Bodoky, G;Dean, A;Shan, YS;Jameson, G;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, RA;Chiu, CF;Schwartsmann, G;Braiteh, F;Moyo, V;Belanger, B;Bayever, E |
| 國家衛生研究院 |
2016-02 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy
|
Chiang, NJ;Yeh, KH;Chiu, CF;Chen, JS;Yen, CC;Lee, KD;Lin, YL;Bai, LY;Chen, MH;Lin, JS;Yang, Y;Rau, KM;Hsiao, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2016-02 |
Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, FS;Moyo, VM;Belanger, B;Bayever, E;Von Hoff, DD;Chen, LT |
| 國家衛生研究院 |
2015-07 |
CARMA3 represses metastasis suppressor NME2 to promote lung cancer stemness and metastasis
|
Chang, YW;Chiu, CF;Lee, KY;Hong, CC;Wang, YY;Cheng, CC;Jan, YH;Huang, MS;Hsiao, M;Ma, JT;Su, JL |
| 亞洲大學 |
2015-07 |
CARMA3 Represses Metastasis-Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis
|
Chang, YW;Chang, YW;Chiu, CF;Chiu, CF;Lee, KY;Lee, KY;Hong, CC;Hong, CC;Wang, YY;Wang, YY;Cheng, CC;Cheng, CC;Jan, YH;Jan, YH;Huang, MS;Huang, MS;Hsiao, M;Hsiao, M;蘇振良 |
| 中國醫藥大學 |
2015-07 |
CARMA3 Represses Metastasis-Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis
|
(Chang YW,);(Chiu CF);(Lee KY);(Hong CC);(Wang YY);(Cheng CC);(Jan YH);(Huang MS);(Hsiao M);(Ma JT);蘇振良(Jen-Liang Su)* |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-03 |
E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer
|
Chen, HA;Chang, YW;Tseng, CF;Chiu, CF;Hong, CC;Wang, W;Wang, MY;Hsiao, M;Ma, JT;Chen, CH;Jiang, SS;Wu, CH;Hung, MC;Huang, MT;Su, JL |
| 國家衛生研究院 |
2015-02 |
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma
|
Tsai, HJ;Lin, SF;Chen, CC;Chen, TY;Su, WC;Hwang, WL;Lin, JC;Chiou, TJ;Kao, WY;Chiu, CF;Chang, YF;Chang, JS;Chang, MC;Su, IJ |
| 國家衛生研究院 |
2015-01 |
Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Chen, LT;Von Hoff, DD;Li, CP;Wang-Gillam, A;Bodoky, G;Dean, AP;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, FS;Moyo, VM;Belanger, B;Bayever, E |
| 國立交通大學 |
2014-12-08T15:27:38Z |
CMOS rotation-invariant pattern recognition system
|
Chiu, CF; Wu, CY |
| 國立交通大學 |
2014-12-08T15:03:14Z |
A NEW STRUCTURE OF THE 2-D SILICON RETINA
|
WU, CY; CHIU, CF |
| 國立交通大學 |
2014-12-08T15:01:54Z |
The design of rotation-invariant pattern recognition using the silicon retina
|
Chiu, CF; Wu, CY |
| 國家衛生研究院 |
2014-12 |
Suppression of dicer increases sensitivity to gefitinib in human lung cancer cells
|
Chen, JC;Su, YH;Chiu, CF;Chang, YW;Yu, YH;Tseng, CF;Chen, HA;Su, JL |
| 國家衛生研究院 |
2014-12 |
Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study
|
Tang, ST;Liu, TW;Liu, LN;Chiu, CF;Hsieh, RK;Tsai, CM |
| 國家衛生研究院 |
2014-12 |
Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-kappaB signaling in cervical cancer
|
Chang, YW;Chen, MW;Chiu, CF;Hong, CC;Cheng, CC;Hsiao, M;Chen, CA;Wei, LH;Su, JL |
| 國家衛生研究院 |
2014-12 |
Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma
|
Su, CM;Su, YH;Chiu, CF;Chang, YW;Hong, CC;Yu, YH;Ho, YS;Wu, CH;Yen, CS;Su, JL |
| 國家衛生研究院 |
2014-11 |
miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression
|
Hong, CC;Chen, PS;Chiou, J;Chiu, CF;Yang, CY;Hsiao, M;Chang, YW;Yu, YH;Hung, MC;Hsu, NW;Shiah, SG;Hsu, NY;Su, JL |
| 亞洲大學 |
2014-09 |
E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer
|
Chen, HA;Chen, HA;Chang, YW;Chang, YW;Tseng, CF;Tseng, CF;Chiu, CF;Chiu, CF;Hong, CC;Hong, CC;Wang, W;Wang, W;Wang, MY;Wang, MY;Hsiao, M;Hsiao, M;Ma JT, ;Chen CH, ;Jiang, SS;Jiang, SS;Wu, CH;Wu, CH;洪明奇;Huang, MT;Huang, MT |
| 亞洲大學 |
2014-09 |
miR-326 maturation is crucial for VEGF-C driven cortactin expression and esophageal cancer progression
|
Hong, CC;Hong, CC;Chen, PS;Chen, PS;Chiou, J;Chiou, J;Chiu, CF;Chiu, CF;Yang, CY;Yang, CY;Hsiao, M;Hsiao, M;Chang, YW;Chang, YW;Yu, YH;Yu, YH;Hung MC, ;Hsu NW, ;S;S;Hsu, NY;Hsu, NY;蘇振良* |
| 中國醫藥大學 |
2014-09 |
miR-326 maturation is crucial for VEGF-C driven cortactin expression and esophageal cancer progression
|
(Hong CC);(Chen PS);(Chiou J);(Chiu CF);(Yang CY);(Hsiao M);(Chang YW, , Hung MC);余養豪(Yang-Hao Yu);洪明奇(Mien-Chie Hung);(Hsu NW,);(Shiah SG);(Hsu NY);蘇振良(Jen-Liang Su)* |
| 中國醫藥大學 |
2014-09 |
E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer
|
(Chen HA);(Chang YW);(Tseng CF);(Chiu CF);(Hong CC);(Wang W);(Wang MY);(Hsiao M);(Ma JT);(Chen CH);(Jiang SS, , Hung MC);(Wu CH);洪明奇(Mien-Chie Hung);(Huang MT);蘇振良(Jen-Liang Su)* |
| 中國醫藥大學 |
2014-09 |
Vascular Endothelial Growth Factor-C Upregulates Cortactin and Promotes Metastasis of Esophageal Squamous Cell Carcinoma
|
(Su CM);(Su YH);(Chiu CF);(Chang YW);(Hong CC);余養豪(Yang-Hao Yu);(Ho YS);(Wu CH);(Yen CS);蘇振良(Jen-Liang Su)* |
| 國家衛生研究院 |
2014-07 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2014-07 |
Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement
|
Ko, BS;Chang, CS;Chang, MC;Chen, TY;Chiou, TJ;Chiu, CF;Huang, WL;Kao, WY;Lan, YJ;Lin, SF;Tan, TD;Tang, JL;Tzeng, CH;Wang, PN;Yet, SP;Tien, HF |
| 亞洲大學 |
2014-07 |
Arsenic Trioxide Inhibits CXCR4-Mediated Metastasis by Interfering miR-520h/PP2A/NF-κB Signaling in Cervical Cancer
|
Chang, YW;Chang, YW;Chen, MW;Chen, MW;Chiu, CF;Chiu, CF;Hong, CC;Hong, CC;Cheng, CC;Cheng, CC;Hsiao, M;Hsiao, M;Chen, CA;Chen, CA;Wei, LH;Wei, LH;蘇振良* |
| 中國醫藥大學 |
2014-07 |
Arsenic Trioxide Inhibits CXCR4-Mediated Metastasis by Interfering miR-520h/PP2A/NF-κB Signaling in Cervical Cancer
|
(Chang YW);(Chen MW);(Chiu CF);(Hong CC);(Cheng CC);(Hsiao M);(Chen CA);(Wei LH);蘇振良(Jen-Liang Su)* |
| 國家衛生研究院 |
2014-06 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL |
| 中國醫藥大學 |
2014-04 |
Suppression of Dicer Increases Sensitivity to Gefitinib in Human Lung Cancer Cells
|
(Chen JC);(Su YH);(Chiu CF);(Chang YW);余養豪(Yang-Hao Yu);(Tseng CF);(Chen HA);蘇振良(Jen-Liang Su)* |
| 亞洲大學 |
2014-02 |
Hospice shared-care saved medical expenditure and reduced the likelihood of intensive medical utilization among advanced cancer patients in Taiwan-a nationwide survey
|
Lin, WY;Lin, WY;Chiu, TY;Chiu, TY;Ho, CT;Ho, CT;Davidson, LE;Davidson, LE;Hsu, HS;Hsu, HS;Liu, CS;Liu, CS;Chiu, CF;Chiu, CF;彭慶添;Peng, Ching-Tien;Chen CY, ;Hu WY, ;Hsu, LN;Hsu, LN;Li, CI;Li, CI;Li, TC;Li, TC;Lin, CY;Lin, CY |
| 國家衛生研究院 |
2014-01 |
Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial
|
Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Chao, Y;Shan, YS;Huang, SF;Chiu, CF;Lee, KD;Chen, LT |
| 臺北醫學大學 |
2014 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates amongTaiwanese terminally ill cancer patients surveyed in2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2013-05 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, LT;Chen, JS;Chao, Y;Tsai, CS;Shan, YS;Hsu, C;Huang, SF;Tsou, HH;Lee, KD;Chiu, CF;Rau, KM;Ho, CL;Yu, MS;Taiwan Cooperative Oncology Group |
| 元培科技大學 |
2013 |
Inhibitory effect and mechanisms of an anthocyanins- and anthocyanidins-rich extract from purple-shoot tea on colorectal carcinoma cell proliferation.
|
Hsu, CP;Shih, YT;Lin, BR;Chiu, CF;Lin, CC. |
| 臺北醫學大學 |
2013 |
Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-ActivatedReceptor ? Activation
|
Weng, JR;Bai, LY;Chiu, CF;Hu, JL;Chiu, SJ;Wu, CY |
| 國家衛生研究院 |
2012-10 |
Front-line concurrent chemoradiotherapy (CCRT) followed consolidation chemotherapy in localized nasal NK/T-cell lymphoma
|
Tsai, HJ;Lin, SF;Chen, CC;Chen, TY;Su, WC;Hwang, WL;Lin, JC;Chiou, TJ;Kao, WY;Chiu, CF;Chang, YF;Chang, SM;Su, IJ;Chang, MC |
| 元培科技大學 |
2012 |
Inhibitory effect and mechanisms of an anthocyanins- and anthocyanidins-rich extract from purple-shoot tea on colorectal carcinoma cell proliferation
|
Hsu, CP;Shih, YT;Lin, BR;Chiu, CF;Lin, CC |
| 國家衛生研究院 |
2011-12 |
Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma
|
Bai, LY;Chiu, CF;Pan, SL;Sargeant, AM;Shieh, TM;Wang, YC;Weng, JR |
| 國家衛生研究院 |
2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou
|
Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY |
| 國家衛生研究院 |
2010-03 |
Cancer care quality assessment in USA, UK and Taiwan
|
Liu, CM;Huang, KC;Chiu, CF;Liu, TW |
| 中國醫藥大學 |
2009-12-06 |
Satisfaction and Factors Associated with Cancer Treatment in Taiwan
|
龔佩珍(Kung, Pei-Tseng);蔡文正(Tsai, Wen-Chen);(Shieh SH);(Chen HS);(Huang CM);(Lung CH);(Chiu CF);(Chen JY);(Liang JA);(Yeh LS);(Ting YM);(Sung YC);(Hsu WL);(Liao CS) |
| 亞洲大學 |
2009-10 |
Association of Genetic Polymorphisms of EXO1 Gene with Risk of Breast Cancer in Taiwan
|
Wang, HC;Wang, Hwei-Chung;Chiu, CF;Chiu, Chang-Fang;Tsai, RY;Tsai, Ru-Yin;Kuo, YS;Kuo, Yung-Shun;Chen, HS;Chen, Hua-Shiang;Wang, RF;Wang, Rou-Fen;Tsai, CW;Tsai, Chia-Wen;Chang, CH;Chang, Chao-Hsiang;Lin, CC;Lin, Cheng-Chieh;Bau, DT;Bau, Da-Tian |
| 國家衛生研究院 |
2008-07 |
An improved SUMO fusion protein system for effective production of native proteins
|
Lee, CD;Sun, HC;Hu, SM;Chiu, CF;Homhuan, A;Liang, SM;Leng, CH;Wang, TF |
| 國家衛生研究院 |
2005-08 |
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis
|
Shen, YC;Chang, CJ;Hsu, C;Cheng, CC;Chiu, CF;Cheng, AL |
| 國家衛生研究院 |
2005 |
Elderly Nutrition and Health Survey in Taiwan (1999-2000): research design, methodology and content
|
Pan, WH; Hung, YT; Shaw, NS; Lin, W; Lee, SD; Chiu, CF; Lin, MC; Chen, SY; Hong, CM; Huang, TY; Chang, HY; Tu, SH; Chang, YH; Yeh, WT; Su, SC |
| 國立臺北護理健康大學 |
2005 |
Elderly nutrition and health survery in Taiwan
|
Pan, WH;Hung, YT;Shaw, NS;Lin, W;Lee, SD;Chiu, CF;Lin, MC;Chen, SY;Wu, SC;Hong, CM;Huang, TY;Chang, HY;Tu, SH;Chang, YH;Yeh, WT;Su, SC |
Showing items 46-95 of 115 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
